Michael Buettcher

Has grant

Klinischer Dozent - University Lecturer

University of Lucerne

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Buettcher is a Klinischer Dozent - University Lecturer at the University of Lucerne in Switzerland. His research areas include pediatric infectious diseases, pharmacometrics, and epidemiology, with recent articles focusing on complicated urinary tract infections in children, superinfections in hospitalized COVID-19 patients, and vaccine hesitancy in central Switzerland. Additionally, he has investigated the microbiological spectrum of infections and the management of various pediatric conditions.

Recent Grants

Grant: Close

AI to Vaccination Documentation

Open Date: 2024-01-01

Close Date: 2024-12-01

Grant: Close

Presentation Publication

Open Date: 2023-11-01

Close Date: 2023-12-01

Grant: Close

Transcend Trial

Open Date: 2023-07-01

Close Date: 2023-12-01

Grant: Close

Ivermectin in scabies infected children

Open Date: 2020-07-01

Close Date:

Grant: Close

Postgraduate Teaching Visits to Resource Poor Countries

Open Date: 2019-04-01

Close Date: 2019-04-01

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (15)

Nicole Ritz

University of Lucerne

SWITZERLAND

Michael Buettcher

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (15)

Surveillance of varicella-associated paediatric hospitalisations and complications in Switzerland from 2021 to 2023

Clinical outcomes and severe complications of hospitalised children and adolescents with varicella in central Switzerland: a retrospective observational study

Guidelines for Complicated Urinary Tract Infections in Children: A Review by the European Society for Pediatric Infectious Diseases

Superinfections in Hospitalized COVID-19 Patients (Super COVID-19): Data from the Multicentric Retrospective CH-SUR Cohort Study in Switzerland

Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg

Tularemia on the rise in Switzerland? A one health approach is needed!

Novel Patient‐Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use

Microbiological Spectrum of Osteoarticular Infections and Their Management in Mongolian Children

Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial.

Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children

Vaccine Hesitancy in Central Switzerland: Identifying and Characterizing Undervaccinated Children in a Pediatric Emergency Department

Phylogeography of Francisella tularensis subspecies holarctica and epidemiology of tularemia in Switzerland.

Monocyte, Lymphocyte and Neutrophil Ratios - Easy-to-Use Biomarkers for the Diagnosis of Pediatric Tuberculosis.

Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study.

Swiss recommendations on perioperative antimicrobial prophylaxis in children

Collaborators (15)

Nicole Ritz

C.T. Berger

Jana Pachlopnik Schmid

Marc Pfister

Geraldine Blanchard-Rohner

Leopold Simma

Carlos Sanchez

Sarah Albini

Petra Zimmermann

Ulrich Heininger

Jan Bonhoeffer

Valeria Guidi

Markus Landolt

Jörg Huwyler

Philipp Baumann

Make your next move.